Intravenous Infusions Plc (GHSE:IIL)
Ghana · Delayed Price · Currency is GHS 0.7500
0.00 (0.00%)
At close: Aug 26, 2026
Intravenous Infusions Market Cap
Intravenous Infusions has a market cap or net worth of 205.81 million as of August 26, 2026. Its market cap has increased by 1,775.00% in one year.
Market Cap
205.81M
Enterprise Value
214.80M
Revenue
6.51M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.75
ChartMarket Cap Chart
Since December 17, 2015, Intravenous Infusions's market cap has increased from 18.13M to 205.81M, an increase of 1,035.19%. That is a compound annual growth rate of 25.49%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 26, 2026 | 205.81M | 1,400.00% |
| Dec 4, 2025 | 13.72M | - |
| Dec 22, 2023 | 13.72M | 6.02% |
| Dec 22, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 4, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Unilever Ghana | 2.20B |
| Fan Milk | 1.54B |
| Enterprise Group | 1.26B |
| SIC Insurance | 1.08B |
| Trust Bank | 480.00M |
| Cocoa Processing Company | 407.61M |
| Clydestone Ghana | 221.00M |
| Dannex Ayrton Starwin | 107.65M |